News

Mauna Kea Technologies reports second quarter and first half of 2020 sales

20 July 2020

First Half of 2020 total sales down 47%; U.S. sales down 19% 
Second Quarter total sales down 72%; U.S. sales down 47% 
Sufficient liquidity to manage the business through the third quarter of 2021 

Latest News

Mauna Kea Technologies Announces Major Milestone for Cellvizio® in Pancreatic Cysts with CLIMB Study Selected for ASGE Presidential Plenary Session at DDW 2026 

Mauna Kea Technologies Announces Major Milestone for Cellvizio® in Pancreatic Cysts with CLIMB Study Selected for ASGE Presidential Plenary Session at DDW 2026 

Mauna Kea Technologies Accelerates International Expansion with New Regulatory Clearances in Switzerland and the United Kingdom 

Mauna Kea Technologies Accelerates International Expansion with New Regulatory Clearances in Switzerland and the United Kingdom 

Mauna Kea Technologies Announces CE MDR Certification For Cellvizio® and Its Associated Probes

Mauna Kea Technologies Announces CE MDR Certification For Cellvizio® and Its Associated Probes

No results found.